The American Journal of Medicine
Volume 123, Issue 7, Supplement , Pages S21-S26, July 2010

The Role of Vasodilating β-Blockers in Patients with Hypertension and the Cardiometabolic Syndrome

  • Addison A. Taylor, MD, PhD

      Affiliations

    • Departments of Medicine, Pharmacology, and Molecular Physiology, Baylor College of Medicine, Houston, Texas, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Addison A. Taylor, MD, PhD, Baylor College of Medicine, 6565 Fannin, MS F504, Houston, Texas 77030
    • ,
  • George L. Bakris, MD

      Affiliations

    • Hypertensive Diseases Unit, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Taylor is supported in part by the National Institutes of Health (NIH).

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9343(10)00341-4

doi:10.1016/j.amjmed.2010.04.015

The American Journal of Medicine
Volume 123, Issue 7, Supplement , Pages S21-S26, July 2010

Article Tools

* Image Usage & Resolution